Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TOPIC: Autophagy Biomarkers in Crohn's Disease
NCT06244849Not yet recruiting
- Sponsor
- Hospices Civils de Lyon
- Start
- Jun 2024
- Primary completion
- Jan 2026
- Countries
- 1
01
Overview
Open-label trial (2 arms), sponsored by Hospices Civils de Lyon. Primary endpoint: Autophagy flux. Planned start Jun 2024; status: not yet recruiting.
Beyond the preview
Go deeper on NCT06244849.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06244849.